Dr. Angela Cano Yuste – Infectious DIseases – Best Researcher Award

Posted on by Innovator Awards

Dr. Angela Cano Yuste - Infectious DIseases - Best Researcher Award

Reina Sofia University Hospital/IMIBIC - Spain 

Author Profile 

SCOPUS 

Early academic pursuits 🎓

Angela Cano Yuste embarked on her academic journey at the Universidad de Córdoba, where she earned her degree in Medicine and Surgery in 2005. Driven by a passion for healthcare and community service, she further specialized in Family and Community Medicine at the Reina Sofia University Hospital, completing her training in 2010. Her quest for knowledge led her to pursue a Master’s in Research Methodology at the Universidad de Córdoba, which she completed in 2017. Angela’s academic achievements culminated in earning a Ph.D. in Medicine from the Biomedicine Program at the Universidad de Córdoba in 2023, solidifying her expertise in the field.

Professional endeavors 👨‍🌾

Angela’s professional career is marked by her dedication to both clinical practice and research. She began her career as an Emergency Physician at the Hospital de Montilla, serving from 2010 to 2018. In 2015, she joined FISEVI-FIBICO as an Investigator in the Infectious Diseases department, where she contributed significantly until 2021. Currently, Angela serves as a Specialist in Infectious Diseases at the Hospital Universitario Reina Sofia, a position she has held since 2021. Her role involves addressing complex infectious diseases, where she applies her extensive knowledge and experience to improve patient outcomes.

Contributions and research focus 🔧

Angela’s research is deeply rooted in the study and management of infectious diseases. Her work has primarily focused on complicated infections, including hospital-acquired pneumonia and Infectious DIseases infections caused by carbapenem-resistant Enterobacteriaceae. Angela has been instrumental as a Principal Investigator in several clinical trials, including those focused on complicated intra-abdominal infections in septic patients and interventional trials targeting hospital-acquired pneumonia and complicated infections. Her research efforts aim to advance the understanding and treatment of these critical conditions, contributing to better clinical practices and patient care.

Accolades and recognition 🌟

Throughout her career, Angela has garnered respect and recognition for her contributions to the field of infectious diseases. Her leadership in clinical trials and her commitment to advancing Infectious DIseases medical research have earned her accolades within the scientific and medical communities. Angela’s work in high-impact clinical studies reflects her dedication to improving healthcare outcomes through rigorous research and evidence-based practice.

Impact and influence 🌍

Angela’s impact extends beyond her immediate clinical and research responsibilities. Her work in infectious diseases has influenced treatment protocols and contributed to the global Infectious DIseases understanding of managing complex infections. Her research findings have helped shape strategies for combating antibiotic-resistant bacteria and improving patient care in hospital settings. Angela’s influence is evident in her contributions to medical literature and her role in guiding future research directions in infectious diseases.

Legacy and future contributions 🔄

Angela Cano Yuste’s legacy lies in her unwavering commitment to medical excellence and research innovation. As she continues her work at the Hospital Universitario Reina Sofia, Angela remains at the forefront of infectious disease research and clinical practice. Her future contributions are poised to further advance the field, particularly in developing new treatment protocols and managing emerging infectious threats. Angela’s dedication ensures that her impact will resonate within the medical community for years to come, inspiring future generations of healthcare professionals..

Notable publications 

  • Title: Invasive aspergillosis in liver transplant recipients in the current era
    Authors: Kimura, M., Rinaldi, M., Kothari, S., Selzner, N., Husain, S.
    Journal: American Journal of Transplantation, 2024, 24(11), pp. 2092–2107
  • Title: Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital
    Authors: López-Viñau, T., Muñoz-Rosa, M., Ruiz-Lara, L.M., Martínez-Martínez, L., Torre-Cisneros, J.
    Journal: Antibiotics, 2024, 13(9), 792
  • Title: Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study
    Authors: Zhou, H., Buetti, N., Pérez-Galera, S., Ozakin, C., Layunta-Acero, R.
    Journal: Journal of Antimicrobial Chemotherapy, 2024, 79(9), pp. 2132–2141
  • Title: Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
    Authors: López-Cortés, L.E., Delgado-Valverde, M., Moreno-Mellado, E., Díaz-López, M.D., Paño, J.R.
    Journal: The Lancet Infectious Diseases, 2024, 24(4), pp. 375–385
  • Title: Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)
    Authors: Paniagua-García, M., Bravo-Ferrer, J.M., Pérez-Galera, S., Sahin, A., Akalin, H.
    Journal: Clinical Microbiology and Infection, 2024, 30(2), pp. 223–230

Prof. Mingqian fang – Immunology & Hematology – Women Researcher Award

Posted on by Innovator Awards

Prof. Mingqian fang - Immunology & Hematology - Women Researcher Award

Kunming Institute of Zoology, Chinese Academy of Sciences - Zimbabwe

Author Profile

ORCID 

Early academic pursuits 🎓

Mingqian fang embarked on his academic journey with a keen interest in biology and medical sciences, eventually specializing in the study of disease pathogenesis. his early work centered on understanding how infections and inflammatory responses influence mental health, particularly focusing on stress-induced depression. his educational background laid a strong foundation for his future research in both neuroscience and cardiovascular diseases. as a professor at the kunming institute of zoology, chinese academy of sciences, he has consistently contributed to groundbreaking research.

Professional endeavors 🏢

As a professor at the kunming institute of zoology, mingqian has dedicated his career to exploring the connections between stress, depression, and physiological responses to infections. his research has not only deepened our understanding of how stress exacerbates mental health disorders, but has also opened pathways to developing effective treatments for both depression and cardiovascular diseases. his expertise extends to studying natural toxin peptides, with particular focus on their biomedical applications.

Contributions and research focus 🔬

Mingqian’s primary research areas include the pathogenesis of diseases like depression under stressful stimuli, such as infections and inflammation, and the Immunology & Hematology development of innovative drugs to treat these conditions. his notable work includes the discovery of how lipopolysaccharide-binding protein expression is increased by stress, promoting depressive symptoms by inhibiting monoamine synthesis. he has also explored the role of bat-derived peptides and how they impact neuroinflammation, contributing significantly to the understanding of the body's immune response to various stressors.

Accolades and recognition 🏅

Mingqian fang’s research has been widely recognized in the scientific community, with publications in high-impact journals such as immunity and pnas. his works have earned accolades due to their novel insights into how biological systems respond to stress and disease. his research in immune responses and toxin peptides has Immunology & Hematology been acknowledged globally, with his papers being published in top-tier journals with high impact factors, demonstrating the importance and quality of his findings.

Impact and influence 🌍

Mingqian’s research has had a far-reaching impact on both neuroscience and cardiovascular medicine. by linking mental health issues like depression to biological processes such as inflammation, he has paved the way for new treatment methodologies. his work on natural toxins also holds promise for creating innovative drugs Immunology & Hematology that could target specific disease mechanisms, further influencing the pharmaceutical industry and biomedical research. his influence spans across multiple fields, combining neuroscience, immunology, and pharmacology.

Legacy and future contributions 🔮

Mingqian fang’s ongoing work ensures that his legacy in the scientific world continues to grow. his pioneering research on stress-related depression and cardiovascular conditions is laying the groundwork for future innovations in drug development. by bridging the gap between neuroscience and immunology, his research will likely inspire further interdisciplinary studies aimed at improving human health. his work on bat-derived peptides, in particular, opens exciting possibilities for novel therapies.

Notable Publications 

  • Title: The Price of P2X7R Freedom is Neuroinflammation
    Authors: Fang M, Lai R
    Journal: Immunity
    Date: March 2024
    DOI: 10.1016/j.immuni.2024.02.009
  • Title: Transferrin Is Up-Regulated by Microbes and Acts as a Negative Regulator of Immunity to Induce Intestinal Immunotolerance
    Authors: Tang X, Fang M, Cheng R, Niu J, Huang X, Xu K, Wang G, Sun Y, Liao Z, Zhang Z et al.
    Journal: Research (Washington, D.C.)
    Date: January 2024
    DOI: 10.34133/research.0301
  • Title: Lipopolysaccharide-Binding Protein Expression is Increased by Stress and Inhibits Monoamine Synthesis to Promote Depressive Symptoms
    Authors: Fang M, Li Y, Liao Z, Wang G, Cao Q, Li Y, Duan Y, Han Y, Deng X, Wu F et al.
    Journal: Immunity
    Date: February 2023
    DOI: 10.1016/j.immuni.2023.02.002
  • Title: An Undefined Cystatin CsCPI1 from Tea Plant Camellia sinensis Harbors Antithrombotic Activity
    Authors: Fang M, Cha JH, Wang HC, Ye P, Chen B, Chen M, Yang WH, Yan X
    Journal: Biomedicine & Pharmacotherapy
    Date: January 2023
    DOI: 10.1016/j.biopha.2023.114285
  • Title: Hypoxia and Low Temperature Upregulate Transferrin to Induce Hypercoagulability at High Altitude
    Authors: Li M, Tang X, Liao Z, Shen C, Cheng R, Fang M, Wang G, Li Y, Tang S, Xie L et al.
    Journal: Blood
    Date: November 2022
    DOI: 10.1182/blood.2022016410

Mr. Anup Kodape – Biological Sciences – Best Researcher Award

Posted on by Innovator Awards

Mr. Anup Kodape - Biological Sciences - Best Researcher Award

Academy of Scientific and Innovative Research - India

Author Profile

SCOPUS

ORCID

Early academic pursuits 🎓

Anup Ramdas Kodape’s academic journey began with a B.Sc. in Botany, Zoology, and Chemistry from Gondwana University, Gadchiroli. He further pursued an M.Sc. in Botany from HISLOP College, Nagpur, where he demonstrated a solid understanding of biological sciences. Currently, he is a Ph.D. candidate in Biological Sciences at CSIR-Central Food Technological Research Institute (CSIR-CFTRI), Mysore, under the Academy of Scientific and Innovative Research. His doctoral research focuses on food protectants and infestation control, particularly targeting the mitigation of aflatoxins in groundnut seeds.

Professional endeavors 🏢

Anup’s professional experience includes a diverse range of roles in both research and teaching. As a Senior Research Fellow at CSIR-CFTRI, Mysore, he is working on developing strategies to mitigate aflatoxins in groundnut seeds. His previous roles include Junior Research Fellow positions at both CSIR-CFTRI and CSIR-National Environmental Engineering Research Institute (NEERI). At NEERI, he worked on CO2 sequestration using algal photobioreactors and air pollution reduction. His teaching experience includes serving as an Assistant Professor at HISLOP College, where he conducted lectures and practicals in botany for undergraduate and postgraduate students.

Contributions and research focus 🔬

Anup’s research is primarily focused on food safety and environmental sustainability. His work at CSIR-CFTRI involves identifying fungal flora in groundnut seeds that produce aflatoxins and developing mitigation strategies using natural compounds, biocontrol, and endophytic challenges. His earlier work at CSIR-NEERI involved CO2 sequestration and air pollution management, showcasing his commitment to addressing Biological Sciences environmental issues through innovative approaches. His contributions significantly advance the understanding and management of aflatoxin contamination and environmental pollution.

Accolades and recognition 🏅

Anup has earned recognition for his academic and research achievements. He has qualified the GATE (Life Sciences) conducted by IIT Bombay Biological Sciences and the UGC NET JRF in Environmental Sciences, which highlights his proficiency in the field. His ongoing Ph.D. research is contributing valuable insights into food safety and environmental protection, garnering respect within the scientific community.

Impact and influence 🌍

Anup’s research has a substantial impact on both food safety and environmental sustainability. His work on aflatoxin mitigation is crucial for improving food security and safety, particularly in groundnut production. Additionally, his contributions to CO2 sequestration and air pollution Biological Sciences reduction are important for addressing global environmental challenges. His research influences practices in food technology and environmental engineering, benefiting both scientific and industrial communities.

Legacy and future contributions 🔮

Anup Ramdas Kodape is poised to leave a lasting legacy in the fields of food safety and environmental science. His innovative research on aflatoxin mitigation and environmental sustainability will likely continue to influence these areas significantly. As he advances in his career, his contributions are expected to further enhance food protection strategies and environmental management practices, contributing to global health and sustainability goals.

Notable Publications

Metagenomic insights of fungal diversity of peanuts under storage conditions and mitigation 2024(1)

Dr. Nathalie Asherie – Medicine and Health Sciences – Best Researcher Award

Posted on by Innovator Awards

Dr. Nathalie Asherie - Medicine and Health Sciences - Best Researcher Award

Hadassah University Medical Center - Israel

AUTHOR PROFILE

SCOPUS

EARLY ACADEMIC PURSUITS

Dr. Nathalie Asherie began her academic journey with a Bachelor of Science in Biotechnology Engineering from ORT Braude College in Karmiel, Israel, graduating cum laude in 2000. She then pursued a Master’s degree in Microbiology at the Hebrew University, Hadassah Medical School, Jerusalem, from 2002 to 2005. Her thesis focused on the involvement of the CD44 molecule in Type 1 diabetes of non-obese diabetic (NOD) mice. She continued her education at the same institution, earning a Ph.D. in Immunology, also with honors, and receiving the Excellence Prize for her Ph.D. thesis in 2012. Her doctoral research delved into the role of CD44 in Type 1 diabetes, identifying a redundant molecule, RHAMM, that supports the migration of inflammatory cells, and examining CD44’s role in β-cell demise.

PROFESSIONAL ENDEAVORS

Dr. Asherie's professional career began with a research associate position at Omrix Biopharmaceuticals, where she contributed to the development of life-saving products derived from human plasma. She then interned at Alomone Labs, focusing on polyclonal antibody design and production. Her extensive industry experience provided a solid foundation for her later roles in academia and clinical research.

CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICINE AND HEALTH SCIENCES

Dr. Asherie's research focuses on finding applicative solutions to immune disorders, including autoimmunity, immune deficiency, and cancer. Her significant contributions include the optimization of anti-BCMA CAR-T cells, process development, Medicine and Health Sciences and CAR humanization. Her work on the anti-BCMA CAR-T based treatment for MM and AL is particularly noteworthy, having enrolled and treated nearly 80 patients. Her innovative research has been published extensively, highlighting her role in advancing cellular therapies and immunological treatments.

IMPACT AND INFLUENCE

Dr. Asherie’s impact is evident in her numerous publications and the successful clinical trials she has led. Her work has garnered recognition in the scientific community, evidenced by awards such as the First Best Abstract Award at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies in 2022 and the Excellence Prize for her Ph.D. thesis. Her contributions to the field of immunology and cellular therapy have influenced current practices and opened new avenues for treatment.

ACADEMIC CITES

Dr. Asherie’s research has been widely cited in the scientific literature, reflecting her influence in the field. Key publications include her work on the anti-BCMA CAR-T cells published in Haematologica and the Journal of Clinical Oncology, Medicine and Health Sciences which have contributed significantly to the understanding and treatment of multiple myeloma and other immune-related disorders. Her research on the molecular mechanisms involving miR-103 in glucocorticoid-induced apoptosis of hemopoietic tumor cells has also been influential.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Asherie’s legacy is marked by her pioneering research and successful implementation of advanced cellular therapies. Her work on CAR-T cell therapy for cancer treatment represents a significant advancement in the field. Moving forward, she aims to continue her research in immunology, focusing on developing novel treatments for immune disorders and enhancing the efficacy of existing therapies. Her commitment to training new personnel and her ongoing contributions to clinical trials ensure that her impact will extend well into the future.

NOTABLE PUBLICATIONS

Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed   2024(1)

Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?   2023(3)

Development and manufacturing of novel locally produced anti-BCMA CART cells for the treatment   2023(9)

Early lymphocyte collection for anti-CD19 CART production improves T-cell fitness in patients with relapsed/refractory  2023(4)

Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis   2022(11)